berberine has been researched along with Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted in 3 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Berberine (BBR) has been previously reported to inhibit hepatoma cell growth, but the main type of cell death elicited by BBR, and whether the alkaloid can inhibit hepatoma cells carrying HCV genomes, is unclear." | 1.56 | Targeting Autophagy Augments BBR-Mediated Cell Death in Human Hepatoma Cells Harboring Hepatitis C Virus RNA. ( Jassey, A; Lin, LT; Liu, CH; Richardson, CD; Tai, CJ; Wong, SH, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Su, J | 1 |
| Zhai, Q | 1 |
| Wei, D | 1 |
| Tai, CJ | 2 |
| Jassey, A | 2 |
| Liu, CH | 2 |
| Richardson, CD | 1 |
| Wong, SH | 2 |
| Lin, LT | 2 |
| Hung, TC | 1 |
| Lin, CJ | 1 |
| Lin, CC | 1 |
| Wang, JY | 1 |
| Yen, MH | 1 |
1 review available for berberine and Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted
| Article | Year |
|---|---|
Recent advancement in small molecules as HCV inhibitors.
Topics: Antiviral Agents; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; RNA | 2022 |
2 other studies available for berberine and Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted
| Article | Year |
|---|---|
Targeting Autophagy Augments BBR-Mediated Cell Death in Human Hepatoma Cells Harboring Hepatitis C Virus RNA.
Topics: Autophagy; Berberine; Carcinoma, Hepatocellular; Cell Death; Cell Proliferation; Hepatitis C; Humans | 2020 |
Berberine inhibits hepatitis C virus entry by targeting the viral E2 glycoprotein.
Topics: Antiviral Agents; Berberine; Cells, Cultured; Hepacivirus; Hepatitis C; Hepatocytes; Host-Pathogen I | 2019 |